Kalydeco 150 MG tablet 56S
Ended Awarded
- Contract number
- SPE2DR26FDDP4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,869
Award facts
- Contract value 100% obligated
- $18,869.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,869.22 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Kalydeco 150 mg tablets (56-unit package). This delivery order, issued on November 3, 2025, with an ultimate completion date of November 4, 2025, represents a firm fixed-price contract with no set-aside designation. DMS Pharmaceutical Group Inc., established as a System for Award Management registrant since 2001, operates as a critical supplier within the federal pharmaceutical supply chain, specializing in distributing comprehensive pharmaceutical products and medical consumables to Department of Defense facilities.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring medical supply needs across military healthcare facilities worldwide. The underlying IDC, valued at $499,999,999 with a completion date of December 31, 2036, establishes DMS Pharmaceutical Group as a regional prime vendor contractor capable of supplying branded and generic prescription medications, biologics, and specialized pharmaceuticals to support Department of Defense healthcare operations globally. The company has demonstrated consistent contract performance across multiple therapeutic categories and product lines through numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division.
Quick answers
Who was awarded contract SPE2DR26FDDP4?
SPE2DR26FDDP4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DR26FDDP4 worth?
The government has obligated $18,869 on SPE2DR26FDDP4.
Is contract SPE2DR26FDDP4 an order under another contract?
Yes. SPE2DR26FDDP4 is a delivery order under SPE2DR25D9102, an indefinite delivery contract.
Was contract SPE2DR26FDDP4 competed?
The extent of competition for SPE2DR26FDDP4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award